Resultados de la búsqueda 301-310 of 5690 for ✌[ 텔레 : SEOGOT ] 구글상단광고프로그램 구글찌라시프로그램판매 구글찌라시프로그램구매 구글찌라시프로그램파는곳 구글찌라프로그램사는곳 웹문서찌라시✌
... program that uses AI-ECG and/or NT-pro-BNP in an at-risk adult cancer survivor population. Study of INBRX-109 in Conventional Chondrosarcoma. Jacksonville ...
The purpose of this study is to evaluate whether encorafenib plus cetuximab (EC), alone or in combination with chemotherapy, can improve clinical outcomes ...
This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating participants with early-stage chronic lymphocytic leukemia or ...
Share · Tweet . VID-20147956. Inicio; Brightcove-Florida PRC director explains program. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?
Jacksonville, Fla. The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) ...
Los médicos de Mayo Clinic están utilizando un robot para telemedicina que les permite estar cara a cara con pacientes que sufrieron un accidente ...
The purpose of this study is to evaluate whether the combination of durvalumab plus lurbinectedin can increase 6 month progression-free survival, in patients ...
Patients' tumors will be sequenced during a pre-registration component or will have had successful sequencing pre-study. A personalized neoantigen peptide ...
There is a need for new treatments for myelofibrosis (MF) patients based on laboratory insight into disease pathogenesis. We will use primary patient samples to ...
Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?